Gastroenterology

This BMS-sponsored promotional symposium, presented at the European Crohn’s and Colitis Organisation (ECCO) Congress 2024, presents a thought-provoking view on the latest developments in therapeutic modalities for ulcerative colitis (UC). 𝗙𝗼𝗿 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗣𝗿𝗼𝗳𝗲𝘀𝘀𝗶𝗼𝗻𝗮𝗹𝘀 𝗼𝗻𝗹𝘆. 𝗧𝗵𝗶𝘀 𝘀𝘆𝗺𝗽𝗼𝘀𝗶𝘂𝗺 𝘄𝗮𝘀 𝗼𝗿𝗴𝗮𝗻𝗶𝘀𝗲𝗱 𝗮𝗻𝗱 𝗳𝘂𝗻𝗱𝗲𝗱 𝗯𝘆 𝗕𝗿𝗶𝘀𝘁𝗼𝗹 𝗠𝘆𝗲𝗿𝘀 𝗦𝗾𝘂𝗶𝗯𝗯. 𝗕𝗠𝗦 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀 𝗮𝗻𝗱/𝗼𝗿 𝗽𝗿𝗼𝗱𝘂𝗰𝘁 𝗶𝗻𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 𝗺𝗮𝘆 𝗯𝗲 𝗱𝗶𝘀𝗰𝘂𝘀𝘀𝗲𝗱. 𝗜𝗠𝗠-𝗚𝗕-𝟮𝟰𝟬𝟬𝟭𝟭𝟮 | 𝗗𝗮𝘁𝗲 𝗼𝗳 𝗣𝗿𝗲𝗽: 𝗔𝗽𝗿𝗶𝗹 𝟮𝟬𝟮𝟰

Explore the latest updates from ACR Convergence 2023, which discusses the emerging developments and trends within rheumatology and their potential relevance to gastroenterology.

This interdisciplinary expert roundtable discussion which highlights data from the American College of Rheumatology (ACR) 2023…

This webinar explores the ATLANTIS trial, a randomised controlled trial investigating amitriptyline as second-line treatment for irritable…

These BMS-sponsored promotional symposia, presented at the European Crohn’s and Colitis Organisation (ECCO) Congress 2023, highlight multidisciplinary perspectives in ulcerative colitis (UC). Current challenges faced in the management of moderate-to-severe UC, and the role of advanced therapies in UC are discussed by both gastroenterologists and IBD specialist nurses. 𝗙𝗼𝗿 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗣𝗿𝗼𝗳𝗲𝘀𝘀𝗶𝗼𝗻𝗮𝗹𝘀 𝗼𝗻𝗹𝘆. 𝗧𝗵𝗲𝘀𝗲 𝘀𝘆𝗺𝗽𝗼𝘀𝗶𝗮 𝘄𝗲𝗿𝗲 𝗼𝗿𝗴𝗮𝗻𝗶𝘀𝗲𝗱 𝗮𝗻𝗱 𝗳𝘂𝗻𝗱𝗲𝗱 𝗯𝘆 𝗕𝗿𝗶𝘀𝘁𝗼𝗹 𝗠𝘆𝗲𝗿𝘀 𝗦𝗾𝘂𝗶𝗯𝗯. 𝗕𝗠𝗦 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀 𝗮𝗻𝗱/𝗼𝗿 𝗽𝗿𝗼𝗱𝘂𝗰𝘁 𝗶𝗻𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 𝗺𝗮𝘆 𝗯𝗲 𝗱𝗶𝘀𝗰𝘂𝘀𝘀𝗲𝗱. 𝗜𝗠𝗠-𝗚𝗕-𝟮𝟯𝟬𝟬𝟯𝟴𝟳 𝗢𝗰𝘁 𝟮𝟯.

Explore the latest insights from EULAR 2023, which discusses the latest developments and research findings on treatment…

Explore the most recent updates from ECCO 2023, which considers the latest insights for IBD management with this expert interdisciplinary…

Explore the latest updates from ACR 2022, which discusses the emerging developments and real-world practices within rheumatology and their…